SCHEMBL20446448

SCHEMBL20446448

CO[C@@H]1C[C@H](C(=O)Nc2cc(CC[C@H](Br)C3CC3)ccc2F)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ KLKB1 P03952 2/20 0.40
▸ F10 P00742 2/20 0.38
▸ LMNA P02545 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MCL1 Q07820 9/20 0.36
▸ UCHL1 P09936 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ BCL2 P10415 1/20 0.34
▸ BCL2L1 Q07817 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ BCR P11274 1/20 0.34
▸ USP30 Q70CQ3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20446506 1.00 CYP1A2 (0.42) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL20446602 0.91 CYP1A2 (0.43) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL20446617 0.91 CYP1A2 (0.43) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL20446536 0.84 KLKB1 (0.38) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL20584575 0.81 KLKB1 (0.51) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL20584573 0.81 KLKB1 (0.51) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL20446447 0.81 KLKB1 (0.51) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL24012307 0.80 CYP1A2 (0.49) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL31456830 0.79 CYP1A2 (0.46) CYP1A2POLBCYP3A4CYP2C19KLKB1
SCHEMBL29581125 0.79 CYP1A2 (0.46) CYP1A2POLBCYP3A4CYP2C19KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3355890-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2018-08-08 — — EP disclosed
Send feedback